Topchoice Medical Co., Inc. 600763.SS
Topchoice Medical Co., Inc. (600763.SS) earns a Piotroski F-score of 7/9 (strong financial health), with an Altman Z″ in the safe zone. It pays a dividend yielding 1.31% (safety: moderate). FY2025 revenue was CN¥2.9B at a 17.2% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
How it ranks in Healthcare · percentile among 79 companies
Percentile vs other Healthcare companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 7/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.055 |
| Retained earnings / assets | 0.65 |
| EBIT / assets | 0.118 |
| Equity / liabilities | 2.875 |
About Topchoice Medical Co., Inc.
Topchoice Medical Co., Inc. offers oral medical services in China. The company is involved in the sale of medical equipment, daily necessities, disinfection products, investment management, import and export business, technology development, technology consulting and technology services, and training services, as well as offers dental medical services. The company was formerly known as Topchoice Medical Investment Co., Inc. and changed its name to Topchoice Medical Co., Inc. in November 2019. Topchoice Medical Co., Inc. was incorporated in 1995 and is based in Hangzhou, China.
FAQ
Is 600763.SS financially healthy?
Topchoice Medical Co., Inc.'s Piotroski F-score is 7/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does 600763.SS pay a dividend, and is it safe?
Yes. Topchoice Medical Co., Inc. pays a dividend yielding about 1.31% with a 41.6% payout ratio, rated “moderate” for safety.
How profitable is 600763.SS?
In FY2025, Topchoice Medical Co., Inc. had a net margin of 17.2% and a return on equity of 11.9%.
Is 600763.SS overvalued or undervalued?
Topchoice Medical Co., Inc. trades at about 31.6× trailing earnings — below its 10-year norm (10-year range 36.6×–94.9×, median 41.1×). Stocktoria reports the data, not buy/sell advice.
Is 600763.SS a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Topchoice Medical Co., Inc.: a Piotroski F-score of 7/9, an Altman Z″ in the safe zone, a P/E of about 31.7×, a dividend yield of 1.31%. Weigh these quality and valuation signals against your own goals.
Computed from company filings · CN · as of 2025-12-31. Figures in CNY. Facts plus Stocktoria's own computed scores — not investment advice.